Program Description: 

Treatment options for patients with newly diagnosed or recurrent thoracic malignancy are in a continual state of evolution.  The MTTC provides pathologists, radiologists, surgeons, medical oncologists and radiation oncologists a forum in which to introduce new treatment options and protocols to the entire team, resulting in a more cohesive and comprehensive plan of care for each patient regardless of the subspecialty via which they entered our Cancer Center’s care.

Communication between the various treating disciplines is crucial in keeping each provider up-to-date on current treatment options.  This forum allows the subspecialists to review each patient’s unique set of physical and psychosocial factors and offer contributions to their care plan which might not otherwise have been recognized. 

The goal is to improve communication amongst the various oncologic disciplines, and increasing each physician and allied health professional’s fund of knowledge and comprehension of available and optimal treatment options.  


ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation:
The Medical College of Wisconsin designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Professionals:
The Medical College of Wisconsin designates this activity for up to 1 hour of participation for continuing education for allied health professionals.


Target audience: 
  • Medical oncologists
  • Radiation oncologists
  • Surgical oncologists
  • Thoracic surgeons
  • Chest radiologists
  • Nuclear medicine radiologists
  • Pathologists
  • Pulmonologists
  • Gastroenterologists
  • Allied health professionals
Learning objectives: 
  • Provide evidence-based recommendations for treatment of newly diagnosed and recurrent thoracic malignancies
  • Remain current on treatment techniques and options, including research protocols, available to thoracic cancer patients
  • Outcomes measurement tools (developed both inside our institution and nationally) are regularly reviewed and discussed, allowing each physician to better evaluate their personal patient care practices and outcomes and adjust treatment strategies accordingly
Faculty & credentials: 
Planning  Committee:
George Haasler, MD
Elizabeth Gore, MD
All persons in control of content have NO relevant financial relationships to disclose, except the following:

Dhiraj Baruah MD

Boehringer Ingelheim PharmaceuticalSpeaker
William Hall MDElekta


Jonathan Kurman MD


Pinacle Biologics
American Medical Forum

In accordance with the ACCME® standard for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.



Patricia Schopp
Phone number: 
+1 (414) 955-6902
Series date: 
01/01/2019 - 7:00am CST to 12/31/2019 - 12:00am CST
Series location: 
Medical College of Wisconsin - Clinical Cancer Center
8800 W Doyne Avenue
Radiation Oncology Conference Room C3200
Milwaukee, WI 53226
United States